Sertraline side effects first week
Pro Research Analysisby 
Searched over 200M research papers
Sertraline Side Effects in the First Week
Common Side Effects: Nausea, Headache, and Insomnia
During the first week of sertraline treatment, patients commonly report experiencing nausea, headache, and insomnia. These side effects are frequently observed in clinical trials and are more prevalent in patients taking sertraline compared to those on a placebo . These symptoms are typical of selective serotonin reuptake inhibitors (SSRIs) and are often transient, subsiding as the body adjusts to the medication.
Gastrointestinal Complaints: Diarrhea and Dry Mouth
Gastrointestinal issues such as diarrhea and dry mouth are also reported by patients during the initial week of sertraline treatment. These side effects are more common in sertraline-treated patients compared to those receiving a placebo 23. While these symptoms can be bothersome, they are generally not severe and tend to diminish with continued use of the medication.
Dizziness and Its Impact on Daily Activities
Dizziness is another side effect that patients may experience during the first week of sertraline treatment. This can affect daily activities and overall quality of life. Studies have shown that dizziness is more frequently reported in patients taking sertraline than in those on a placebo 23. Patients are advised to be cautious when performing tasks that require full alertness, such as driving or operating heavy machinery, until they know how sertraline affects them.
Monitoring and Managing Side Effects
It is crucial for clinicians to monitor patients for these side effects during the first week of sertraline treatment. Adjustments to the dosage or supportive care measures may be necessary to manage these symptoms effectively. In some cases, side effects may be severe enough to warrant discontinuation of the medication, although this is relatively rare.
Conclusion
In summary, the first week of sertraline treatment is often associated with side effects such as nausea, headache, insomnia, gastrointestinal complaints, and dizziness. These symptoms are generally mild to moderate in severity and tend to decrease as treatment continues. Clinicians should closely monitor patients during this period to manage any adverse effects and ensure the best possible outcome.
Sources and full results
Most relevant research papers on this topic